FDA grants citizen petition on glucomannan as a dietary fiber
The U.S. Food and Drug Administration (FDA) has announced that it intends to propose that “glucomannan” be added to the definition of dietary fiber.
The U.S. Food and Drug Administration (FDA) has announced that it intends to propose that “glucomannan” be added to the definition of dietary fiber. The action is being taken in response to a citizen petition from The Food Lawyers.
According to the FDA, dietary fiber that can be declared on the Nutrition and Supplement Facts labels includes certain naturally occurring fibers that are “intrinsic and intact” in plants and added isolated or synthetic non-digestible soluble and insoluble carbohydrates that the agency has determined have physiological effects that benefit human health.
The FDA established a definition for dietary fiber in its 2016 Nutrition Facts label final rule. Based on available evidence, the agency has determined that the scientific evidence suggests that glucomannan can help reduce blood cholesterol. Glucomannan is commonly found in the tuber or root of the elephant yam, also known as the konjac plant.
With this current notification for glucomannan, 17 categories of non-digestible carbohydrates (including a broad category of mixed plant cell wall fibers) are either included in the definition of dietary fiber, or are non-digestible carbohydrates that the FDA intends to propose to be added to the definition of dietary fiber.
Until the FDA completes rulemaking to add additional fibers to the regulatory definition of dietary fiber, the agency intends to exercise enforcement discretion to allow manufacturers to include the amount of these additional fibers in the dietary fiber declaration on the Nutrition and Supplement Facts labels.
More News
FDA amends its procedures for dairy, infant formula firms exporting to China
The U.S. Food and Drug Administration (FDA) is announcing changes to its export listing procedures for dairy and infant formula firms seeking to export their products to China.
FDA amends its procedures for dairy, infant formula firms exporting to China
The U.S. Food and Drug Administration (FDA) is announcing changes to its export listing procedures for dairy and infant formula firms seeking to export their products to China.
FDA gives $1.5 million to support FSMA education, training, and technical assistance
The FDA is announcing $1.5 million of continued funding, in the form of cooperative agreements, to the University of Arkansas Indigenous Food and Agriculture Initiative and the National Farmers Union to enhance food safety under the FDA Food Safety Modernization Act (FSMA).
FDA gives $1.5 million to support FSMA education, training, and technical assistance
The FDA is announcing $1.5 million of continued funding, in the form of cooperative agreements, to the University of Arkansas Indigenous Food and Agriculture Initiative and the National Farmers Union to enhance food safety under the FDA Food Safety Modernization Act (FSMA).
FDA announces qualified health claim for cranberry products and urinary tract infections
The U.S. FDA has announced in a letter of enforcement discretion that it does not intend to object to the use of certain qualified health claims regarding consuming certain cranberry products and a reduced risk of recurrent urinary tract infection in healthy women.
